Diagnos Laboratorium Utama Tbk. vs SLJ Global Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 27.5K 24h volume), while SLJ Global Tbk. trades at Rp79 (market cap 499.34B, 560.5K 24h volume). The key difference: SLJ Global Tbk. is the larger of the two by market cap, and SLJ Global Tbk. is more actively traded (560.5K versus 27.5K). Which is the better fit depends on your goals.
| DGNS | SULI | |
|---|---|---|
Market Cap | 308B | 499.34B |
Volume | 27.5K | 560.5K |
Lot | 275 | 5.61K |
Turnover | 6.23M | 44.35M |
Average Price | 226.59 | 79.12 |
Value | 6.23M | 44.35M |
Indicative Equilibrium Price | 230 | 80 |
Indicative Equilibrium Volume | 110 | 76 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT SLJ Global (the Company) was established under the name of PT. Sumalindo Lestari Jaya in the Republic of Indonesia based on Notarial Deed No. 10 dated April 14, 1980, of Rukmasanti Hardjasatya , S.H., as amended by Deed No. 1 dated June 3, 1980, of the same notary.
Read more on SULI →